BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Medtronic Limited (MDT) Launches Its First Integrated Power Console (IPC) Platform for Use in Spinal, Cranial, and Ear, Nose, and Throat Surgeries


1/5/2009 7:18:40 AM

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT - News) announced today the launch of the Integrated Power Console (IPC™) platform, its first multispecialty surgical power console for use in spinal, cranial, and ear, nose, and throat (ENT) surgeries. The console powers Medtronic’s Midas Rex® Legend EHS® and Legend EHS Stylus® drills, used primarily in spinal and cranial applications, and the Straightshot® M4 Microdebrider, Visao,® and Skeeter® drills used in ENT and neurotology procedures. The console also powers the newly released Midas Rex Spine Shaver, which enables powered tissue removal during spinal surgeries.

“The IPC platform goes a long way toward helping hospitals streamline their ORs,” said Bob Blankemeyer, president of the Surgical Technologies business and senior vice president at Medtronic. “It is our first, true cross-specialty power platform and represents a significant advancement from power consoles previously available in the neurologic, spine and ENT markets. The powered instruments we design in the coming years will be built to run on the IPC platform.”

To increase functionality, the console includes integrated irrigation with IntelliFlow™ remote control and redesigned tubing, plus expanded handpiece options. An intuitive touchscreen interface, IV-pole mount and the three-button non-slip foot pedal make the IPC system easy to use.

Along with the IPC platform, Medtronic launched the Stim Bur Guard for the Visao High-Speed Otologic Drill. Stim Bur technology works with Medtronic’s NIM-Response® 2.0 and NIM-Neuro® 2.0 intraoperative nerve monitors to alert surgeons of proximity to the facial nerve during surgery. It is the first and only commercially available surgical tool that combines an electric drill with stimulation.

The Spine Shaver offers an alternative to multi-instrument techniques for spinal surgery by allowing rapid, controlled tissue removal through a single entry point. This technology allows surgeons to reduce the number of passes into the surgical space, while the aspirating blade allows for rapid excision.

About the Surgical Technologies Business at Medtronic

Medtronic’s Surgical Technologies business develops products for the diagnosis and treatment of chronic diseases and disorders of the ear, nose and throat; surgical devices and implantable products for the treatment of cranial, spinal and specialty small-bone conditions; and state-of-the-art navigation equipment used in operating rooms to assist physicians in neuro and spinal surgery procedures.

About Medtronic

Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s Annual Report on Form 10-K for the year ended April 25, 2008. Actual results may differ materially from anticipated results.

™Trademarks of Medtronic, Inc. ®Registered marks of Medtronic, Inc.

Contact:

Medtronic, Inc. Public Relations: Ginny Cassidy, 763-505-2998 or Investor Relations: Jeff Warren, 763-505-2696

Source: Medtronic, Inc.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES